R3 XLPE ANTEVERTED LINERS
K-Number: K102370 · 2011-01-19
Advertisement
Device Summary
Frequently Asked Questions
What is the R3 XLPE ANTEVERTED LINERS?
R3 XLPE ANTEVERTED LINERS is a medical device that received FDA 510(k) clearance on 2011-01-19. The listed applicant is Smith & Nephew, Inc.. The 510(k) number is K102370.
When did R3 XLPE ANTEVERTED LINERS receive FDA 510(k) clearance?
R3 XLPE ANTEVERTED LINERS received FDA 510(k) clearance on 2011-01-19, under 510(k) number K102370.
Who is the listed applicant for R3 XLPE ANTEVERTED LINERS?
The FDA 510(k) record lists Smith & Nephew, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for R3 XLPE ANTEVERTED LINERS?
The FDA product code for R3 XLPE ANTEVERTED LINERS is MBL.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Smith & Nephew, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: MBL)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement